Capricor Therapeutics Announces Intent to File Biologics License Application for Full Approval of Deramiocel for the Treatment of Duchenne Muscular Dystrophy Cardiomyopathy Coronary/Structural Heart September 24, 2024 by Ken Dropiewski Comments are Disabled -BLA to be Supported by Existing and Natural History Cardiac Data as Discussed with the FDA- Continue Reading →